Skip to content

Secukinumab

Also known as Cosentyx (us), Scapho (india)

Autoimmune & Inflammation
Save $164,179/mo
32× cheaper

An IL-17 biologic for psoriasis and psoriatic / axial arthritis.

United States
$169,511
per month
India
$5,332
per month
You save
$164,179
97% cheaper in India
178.4K US scripts/yr$29.3B potential annual savings$30.2B US spend/yr
Compare the price
US price$2,600per month
India price$300per month
You save$2,30088% less

Based on 2 pens per month. US $1,300.00 vs India $150.00 per pen.

Total over 1 periodSave $2,300$2,600$300
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$13,800
Estimated travel cost
− $2,300
Net savings after travel
$11,500

Even after travel, you could come out ahead by about $11,500.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Secukinumab is filled about 178.4K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$30.2B
If sourced from India
$951M
Potential annual savings
$29.3B
97%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.